GEN23h
AI Collaboration Between Sanofi and Healx Will Target Novel Rare Diseases Indications
Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.
Healx announces agreement with Sanofi to seek new rare disease indications for compound using AI drug discovery platform
Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced it will use a Sanofi compound to identify new disease indications using Healnet, Healx’s AI-driven ...
Business Weekly2d
Healx and Sanofi unite to probe new disease indications
Healx is an AI-enabled, clinical-stage biotech company and was named Life Science AI champion at September’s Business Weekly ...